Arcutis (ARQT) Achieves $44.8M in Q3 2024 Revenue, Growing 452% Year-Over-Year
Arcutis Biotherapeutics Inc. (ARQT) is a commercial-stage biopharmaceutical company dedicated to revolutionizing the treatment of immune-mediated skin diseases.…
Browsing Tag